Opioid Therapy Program management resources
December 15, 2022
Disclaimer: This article was published in 2022 and reflects the information available at that time. As a PDL NSW member, you may have seen
Disclaimer: This article was published in 2022 and reflects the information available at that time. As a PDL NSW member, you may have seen
Disclaimer: This article was published in 2022 and reflects the information available at that time. The recent availability of the Moderna Spikevax Bivalent Booster
Disclaimer: This article was published in 2022 and reflects the information available at that time. Each year, PDL receives calls from pharmacists who have
Disclaimer: This article was published in 2022 and reflects the information available at that time. PDL NSW members were recently sent a Forum communique
Disclaimer: This article was published in 2022 and reflects the information available at that time. The Pharmacy Council of NSW has launched a new
Disclaimer: This article was published in 2022 and reflects the information available at that time. Pharmacists practising in Queensland are advised the UTIPP-Q pilot
Disclaimer: This article was published in 2022 and reflects the information available at that time. PDL continues to see notifications involving forged prescriptions and
Disclaimer: This article was published in 2022 and reflects the information available at that time. Pharmacists practising in Queensland are advised that after Friday,
Disclaimer: This article was published in 2022 and reflects the information available at that time. PDL has recently received several incident reports where the
Disclaimer: This article was published in 2022 and reflects the information available at that time. It is no surprise that the top four drugs
Pharmaceutical Defence Limited (PDL) acknowledges the Traditional Owners of Country throughout Australia and their continuing connection to land, waters and community. We pay our respects to the people, the cultures and the Elders past and present.